» Articles » PMID: 21413894

Menstrual Concerns and Intrauterine Contraception Among Adolescent Bariatric Surgery Patients

Overview
Date 2011 Mar 19
PMID 21413894
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Adolescent obesity has dramatically increased in recent decades, and along with that so have other medical comorbidities, such as hypertension, diabetes, hyperlipidemia, nonalcoholic steatohepatitis, polycystic ovary syndrome (PCOS), and pseudotumor cerebri. Obesity and related comorbidites may be contraindications to hormonal contraception, making contraception counseling of morbidly obese adolescents more challenging. Obese adolescent females seeking bariatric surgery need effective contraception in the postoperative period. This study is designed to determine the acceptance rate of the levonorgestrel-releasing intrauterine device (IUD) and describe common menstrual problems in obese adolescent bariatric surgery patients.

Methods: This is a historic cohort study of adolescent females who underwent bariatric surgery over a 2-year period at a tertiary referral center for pediatric obesity. Data were systematically abstracted. The percent of patients with menstrual problems and the acceptance rate for the levonorgestrel-releasing IUD were determined.

Results: Twenty-five adolescents met inclusion criteria. The mean age was 17.4 years (standard deviation [SD] 2.6), and the mean body mass index (BMI) was 51.4 (SD 6.3) kg/m(2). Eighty-four percent were white. Twenty-eight percent had menorrhagia, 32% had oligomenorrhea, 40% had dysmenorrhea, and 36% had PCOS. Ninety-two percent (23 of 25) underwent IUD placement.

Conclusions: There was a high prevalence of menstrual problems among this sample of severely obese adolescent females. The majority accepted the IUD, indicating it is a viable option among this population.

Citing Articles

Body Mass Index and Levonorgestrel Device Expulsion in Adolescents and Young Adults.

Masten M, Yi H, Beaty L, Hutchens K, Alaniz V, Buyers E J Pediatr Adolesc Gynecol. 2024; 37(4):407-411.

PMID: 38462038 PMC: 11706623. DOI: 10.1016/j.jpag.2024.03.001.


Beyond the Metabolic Syndrome: Non-Obvious Complications of Obesity in Children.

Koziol-Kozakowska A, Janus D, Stepniewska A, Szczudlik E, Stochel-Gaudyn A, Wojcik M Children (Basel). 2023; 10(12).

PMID: 38136107 PMC: 10742254. DOI: 10.3390/children10121905.


Metabolic hormones are integral regulators of female reproductive health and function.

Athar F, Karmani M, Templeman N Biosci Rep. 2023; 44(1).

PMID: 38131197 PMC: 10830447. DOI: 10.1042/BSR20231916.


Childhood Obesity: Position Statement of Polish Society of Pediatrics, Polish Society for Pediatric Obesity, Polish Society of Pediatric Endocrinology and Diabetes, the College of Family Physicians in Poland and Polish Association for Study on....

Mazur A, Zachurzok A, Baran J, Deren K, Luszczki E, Weres A Nutrients. 2022; 14(18).

PMID: 36145182 PMC: 9505061. DOI: 10.3390/nu14183806.


The effects of obesity on the menstrual cycle.

Itriyeva K Curr Probl Pediatr Adolesc Health Care. 2022; 52(8):101241.

PMID: 35871162 PMC: 9449629. DOI: 10.1016/j.cppeds.2022.101241.


References
1.
dArcangues C . Worldwide use of intrauterine devices for contraception. Contraception. 2007; 75(6 Suppl):S2-7. DOI: 10.1016/j.contraception.2006.12.024. View

2.
Jick S, Walker A, Jick H . Oral contraceptives and endometrial cancer. Obstet Gynecol. 1993; 82(6):931-5. View

3.
Stanwood N, Bradley K . Young pregnant women's knowledge of modern intrauterine devices. Obstet Gynecol. 2006; 108(6):1417-22. DOI: 10.1097/01.AOG.0000245447.56585.a0. View

4.
Pasquali R, Casimirri F, Plate L, Capelli M . Characterization of obese women with reduced sex hormone-binding globulin concentrations. Horm Metab Res. 1990; 22(5):303-6. DOI: 10.1055/s-2007-1004907. View

5.
Roehrig H, Xanthakos S, Sweeney J, Zeller M, Inge T . Pregnancy after gastric bypass surgery in adolescents. Obes Surg. 2007; 17(7):873-7. DOI: 10.1007/s11695-007-9162-7. View